CMS Adopts AMA Coding Recommendations For Cancer Drug Administration
This article was originally published in The Pink Sheet Daily
Executive Summary
New codes will allow reimbursement for each infusion of chemotherapy and non-chemo drugs as well as for preparation of pharmaceuticals and management of adverse events. CMS is awaiting a GAO report on average sales price-based reimbursement.